The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an insufficient effect.

Researchers at St. Michael's Hospital have published the first detailed figures showing the risk of using the prescription drug Rasilez in combination with certain other blood pressure-lowering medications.

Women with high blood pressure (hypertension) during early pregnancy are more likely to have babies born with major birth defects, regardless of their use of prescribed medications to control the condition.

Patients with high blood pressure who are given combined drug therapy from the start of treatment respond better than patients given single-drug treatment (monotherapy), according to a new study.

EAST HANOVER, N.J., Dec. 22, 2010 /PRNewswire/ -- Today Novartis announced that the US Food and Drug Administration (FDA) approved Amturnide (aliskiren, amlodipine and hydrochlorothiazide) tablets for the treatment of high blood pressure.